Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism

20247 citationsJournal Articlehybrid Open Access

Authors

Martin Miner · Miriam Hospital

Christina Wang · UCLA Medical Center

Jed Kaminetsky · Manhattan Scientifics (United States)

M Khera · Baylor College of Medicine

Irwin Goldstein · Pomerado Hospital

Culley C. Carson · University of North Carolina at Chapel Hill

Nachiappan Chidambaram

Abstract

Male patients with hypogonadism receiving oral testosterone undecanoate 225 mg twice daily demonstrated improvements in libido and sexual frequency. Serum testosterone concentrations were within the reference range in 87% of patients without dose titration.

Topics & Keywords

Hormonal and reproductive studies Hypothalamic control of reproductive hormones Pharmacology and Obesity Treatment

Publication Details

Published in: Andrology

Volume 13, Issue 4, pp. 882-893

DOI: 10.1111/andr.13747

Field-Weighted Citation Impact: 2.55

Command Palette

Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism

Authors

Abstract

Topics & Keywords

Publication Details